Study reveals key mechanism of PD-1 function

Insights into the workings of an immune cell surface receptor, called PD-1, reveal how treatments that restrict its action can potentially be strengthened to improve their anticancer effect, a new study shows.

Related Keywords

New York ,United States ,Norway ,Tarragona ,Comunidad Autonoma De Cataluna ,Spain ,University Of Texas ,Texas ,Houston ,Oslo ,United Kingdom ,Columbia University ,Audun Kvalvaag ,Ruimin Pan ,Hong Liang ,Xiang Peng Kong ,Jun Wang ,Ian Ahearn ,Christina Luo ,Zhihua Qin ,Elliot Philips ,Kadam Mor ,Dan Littman ,Jia Liu ,Michael Dustin ,Alexander Leithner ,Alexander Morch ,Yong Zhou ,Anna Tocheva ,Antonio Garcia Espana ,Kennedy Trust For Rheumatology Research ,Colton Center ,Langone Health Perlmutter Cancer Center ,Department Of Biochemistry ,National Institutes Of Health ,Research Council Of Norway ,Perlmutter Cancer Center ,Department Of Pathology ,Bristol Myers Squibb ,Grossman School Of Medicine ,Vilcek Institute Of Biomedical Sciences ,Langone Health ,Philips ,Melanoma Research Alliance ,Icahn School Of Medicine At Mount Sinai ,University Of Oxford ,University Of Rovirai Virgili ,Wellcome ,Nyu Langone Health ,Howard Hughes Medical Institute ,Oslo University ,Science Immunology ,Study Lead Investigator ,Perlmutter Cancer ,Vilcek Institute ,Biomedical Sciences ,Molecular Pharmacology ,National Institutes ,Kennedy Trust ,Rheumatology Research ,Research Council ,Marie Sklodowska Curie Actions ,Wellcome Trust ,Rootpath Genomics ,Hanmi Pharmaceutical ,Icahn School ,Mount Sinai ,